FSG is a Lund-based venture capital firm investing in early-stage, revenue-generating startups at the intersection of life science and technology across the Nordics and Europe, including Denmark. The firm targets sectors including biotechnology, healthtech, medical devices, pharmaceuticals and deep tech, and typically invests €1M-€6M. FSG has acted as a co-lead investor in a Series A financing, making it relevant for founders seeking hands-on venture backing for technical life-sciences companies.